Moreover, the block of MYCN by the anti-MYCN BGA002 is able to reactivate and restore the effectiveness of natural killer immune cells against NB, reverting the role of MYCN as a driver of a tumor immunosuppressive environment which impacts survival in several MYCN-positive tumors [156]. This evidence concerns the gene MYCN and neoplasm.